Covid19

Moderna seeks to dismiss Alnylam suit over Covid-19 vaccine component, claiming wrong venue

… use of Alnylam's biodegradable lipids, which Alnylam claims have been integral to the way both companies' mRNA-based Covid-19 vaccines work.

Read more at endpts.com

Show More

Related Articles

Back to top button